Context Other Operating Expenses from 2010 to 2025

CNTX Stock  USD 0.84  0  0.12%   
Context Therapeutics Other Operating Expenses yearly trend continues to be fairly stable with very little volatility. Other Operating Expenses is likely to outpace its year average in 2025. Other Operating Expenses is expenses incurred from non-core business activities, including administrative and general expenses, but excluding costs directly related to production. View All Fundamentals
 
Other Operating Expenses  
First Reported
2010-12-31
Previous Quarter
28.8 M
Current Value
30.3 M
Quarterly Volatility
9.3 M
 
Credit Downgrade
 
Yuan Drop
 
Covid
Check Context Therapeutics financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Context Therapeutics' main balance sheet or income statement drivers, such as Interest Expense of 435.1 K, Selling General Administrative of 9.1 M or Total Revenue of 0.0, as well as many indicators such as Price To Sales Ratio of 0.0, Dividend Yield of 0.0 or PTB Ratio of 1.44. Context financial statements analysis is a perfect complement when working with Context Therapeutics Valuation or Volatility modules.
  
Check out the analysis of Context Therapeutics Correlation against competitors.
For more information on how to buy Context Stock please use our How to Invest in Context Therapeutics guide.

Latest Context Therapeutics' Other Operating Expenses Growth Pattern

Below is the plot of the Other Operating Expenses of Context Therapeutics over the last few years. Other Operating Expenses is the expense which generally does not depend on sales or production quantities of Context Therapeutics. It is also known as Context Therapeutics overhead expenses. Typically these expenses include marketing, rent and utilities, office, leases, and other overhead cost. It is expenses incurred from non-core business activities, including administrative and general expenses, but excluding costs directly related to production. Context Therapeutics' Other Operating Expenses historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Context Therapeutics' overall financial position and show how it may be relating to other accounts over time.
Other Operating Expenses10 Years Trend
Slightly volatile
   Other Operating Expenses   
       Timeline  

Context Other Operating Expenses Regression Statistics

Arithmetic Mean10,177,757
Geometric Mean7,607,743
Coefficient Of Variation91.18
Mean Deviation7,293,936
Median5,377,144
Standard Deviation9,279,846
Sample Variance86.1T
Range27.7M
R-Value0.74
Mean Square Error41.7T
R-Squared0.55
Significance0
Slope1,442,634
Total Sum of Squares1291.7T

Context Other Operating Expenses History

202530.3 M
202428.8 M
202325.1 M
202214.9 M
20217.4 M
20202.6 M

About Context Therapeutics Financial Statements

Context Therapeutics investors use historical fundamental indicators, such as Context Therapeutics' Other Operating Expenses, to determine how well the company is positioned to perform in the future. Understanding over-time patterns can help investors decide on long-term investments in Context Therapeutics. Please read more on our technical analysis and fundamental analysis pages.
Last ReportedProjected for Next Year
Other Operating Expenses28.8 M30.3 M

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

Additional Tools for Context Stock Analysis

When running Context Therapeutics' price analysis, check to measure Context Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Context Therapeutics is operating at the current time. Most of Context Therapeutics' value examination focuses on studying past and present price action to predict the probability of Context Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Context Therapeutics' price. Additionally, you may evaluate how the addition of Context Therapeutics to your portfolios can decrease your overall portfolio volatility.